Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 73501-73550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05732831
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
PHASE1/PHASE2Recruiting
225 participants
Started: May 26, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor25 locations
NCT05729607
Vertical Soft Tissue Augmentation With CTG vs ADM
NARecruiting
28 participants
Started: May 26, 2023 · Completed: Nov 27, 2027
1 condition1 sponsor1 location
NCT05484115
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
NARecruiting
300 participants
Started: May 26, 2023 · Completed: Apr 30, 2033
1 condition2 sponsors27 locations
NCT05590468
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy
PHASE2Active, not recruiting
34 participants
Started: May 26, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05862584
Impact of Air Pollution on the Course of Inflammatory Rheumatism
NAActive, not recruiting
86 participants
Started: May 26, 2023 · Completed: Dec 30, 2024
3 conditions1 sponsor1 location
NCT05856877
Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D
NARecruiting
180 participants
Started: May 26, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04497259
Follow-up of Bariatric Surgery by Teleconsultations
NARecruiting
64 participants
Started: May 26, 2023 · Completed: Feb 26, 2025
1 condition1 sponsor1 location
NCT05796206
A Clinical Study of MIL62 in Systemic Lupus Erythematosus
PHASE2/PHASE3Recruiting
200 participants
Started: May 26, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05428267
Sexual Dysfunction in Cirrhosis
NARecruiting
150 participants
Started: May 26, 2023 · Completed: Jan 26, 2026
1 condition1 sponsor1 location
NCT05674422
GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.
N/AActive, not recruiting
120 participants
Started: May 26, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor15 locations
NCT05369195
Cerebral Protection in Transcatheter Left Atrial Appendage Occlusion
NARecruiting
240 participants
Started: May 26, 2023 · Completed: Sep 30, 2026
4 conditions4 sponsors6 locations
NCT05824546
uSINE-PAMS Artificial Intelligence Driven, Ultrasound-Guided Lumbar Puncture to Improve Procedural Accuracy
NARecruiting
50 participants
Started: May 26, 2023 · Completed: Jul 31, 2024
2 conditions2 sponsors1 location
NCT05878288
Deep sequencIng in Cutaneous Squamous CEll caRciNomas
PHASE2Active, not recruiting
11 participants
Started: May 26, 2023 · Completed: May 31, 2029
4 conditions6 sponsors1 location
NCT05589818
Pembrolizumab for Advanced NSCLC and PS 2-3
PHASE2Recruiting
45 participants
Started: May 26, 2023 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT06014892
The 4th Trimester Initiative: The Impact of Parental Support on Pregnant Trainee Wellbeing
NAActive, not recruiting
152 participants
Started: May 25, 2023 · Completed: Dec 31, 2025
3 conditions4 sponsors4 locations
NCT05890742
A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With Sintilimab, for Neoadjuvant Treatment of MSI-H/dMMR Resectable Colon Cancer
PHASE3Recruiting
360 participants
Started: May 25, 2023 · Completed: Jul 15, 2028
1 condition1 sponsor1 location
NCT06736249
HIF-1α Stabilization As a Novel Therapeutical Approach for Sarcopenia.
NARecruiting
105 participants
Started: May 25, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06694779
Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study
N/ARecruiting
1,000 participants
Started: May 25, 2023 · Completed: May 25, 2026
2 conditions2 sponsors1 location
NCT06189612
Manual Therapy and Movement Control Exercises for Chronic Neck Pain. A Pilot Randomized Controlled Trial
NARecruiting
45 participants
Started: May 25, 2023 · Completed: Dec 31, 2024
2 conditions4 sponsors1 location
NCT05822245
A Study of PER-001 in Participants With Open-Angle Glaucoma
PHASE1/PHASE2Active, not recruiting
36 participants
Started: May 25, 2023 · Completed: Apr 4, 2026
1 condition1 sponsor1 location
NCT06417060
Caudal Anesthesia Versus Local Anesthesia in Hypospadias
NARecruiting
200 participants
Started: May 25, 2023 · Completed: Aug 30, 2024
4 conditions1 sponsor3 locations
NCT06833632
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
N/ARecruiting
100 participants
Started: May 25, 2023 · Completed: Sep 11, 2025
1 condition1 sponsor1 location
NCT05821452
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma
PHASE2Not yet recruiting
40 participants
Started: May 25, 2023 · Completed: May 30, 2026
2 conditions1 sponsor1 location
NCT05289687
Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL
PHASE2Recruiting
20 participants
Started: May 25, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT05867615
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours:
PHASE2Active, not recruiting
83 participants
Started: May 25, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT05885464
A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)
PHASE1/PHASE2Active, not recruiting
5 participants
Started: May 25, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor10 locations
NCT05812235
Bone Microstructure by Using HR-pQCT After Esophagectomy
N/ANot yet recruiting
118 participants
Started: May 25, 2023 · Completed: Mar 31, 2027
3 conditions1 sponsor0 locations
NCT06148675
Macrowire for IntracraNial Thrombectomy
N/AActive, not recruiting
200 participants
Started: May 25, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT06785441
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
N/ARecruiting
180 participants
Started: May 25, 2023 · Completed: Feb 2, 2030
1 condition2 sponsors1 location
NCT06606548
Comprehensive Oral Care Long-term Care Facilities
NAActive, not recruiting
100 participants
Started: May 25, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05699772
Expanding Delivery of an Evidence-based Weight-loss Intervention to Enhance Access and Reach Underserved Groups After TBI
NAActive, not recruiting
85 participants
Started: May 25, 2023 · Completed: Aug 31, 2027
1 condition3 sponsors1 location
NCT05857800
Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment
N/ARecruiting
2,000 participants
Started: May 25, 2023 · Completed: May 25, 2033
1 condition1 sponsor1 location
NCT05888532
64Cu-GRIP B in Patients With Advanced Malignancies
PHASE1/PHASE2Recruiting
91 participants
Started: May 25, 2023 · Completed: Jan 31, 2027
6 conditions3 sponsors1 location
NCT05906082
Vape-Free Text-Messaging: Pilot Study
NARecruiting
50 participants
Started: May 25, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06883422
Pre-Surgical Immunonutrition's Effect on Colorectal Surgery
NARecruiting
126 participants
Started: May 25, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT07028944
Analysis of Medial Clear Space Widening in Weber B Ankle Fractures
N/AEnrolling by invitation
60 participants
Started: May 25, 2023 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06746701
Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.
N/ARecruiting
400 participants
Started: May 25, 2023 · Completed: May 25, 2029
1 condition1 sponsor4 locations
NCT05859750
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
PHASE2Recruiting
78 participants
Started: May 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT05317832
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
PHASE2Recruiting
196 participants
Started: May 25, 2023 · Completed: Sep 30, 2026
1 condition8 sponsors1 location
NCT05847790
Remote Pregnancy Monitoring to Improve Access
NAActive, not recruiting
400 participants
Started: May 25, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05572359
Cryo and Compression Therapy After TKA and UKA
NAActive, not recruiting
208 participants
Started: May 25, 2023 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT05877534
Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study
NAEnrolling by invitation
60 participants
Started: May 25, 2023 · Completed: Jun 1, 2026
4 conditions2 sponsors1 location
NCT05828147
Anti-CD20 Antibodies for Treatment of SLE-PAH
PHASE4Recruiting
50 participants
Started: May 25, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05660954
Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
PHASE2Active, not recruiting
41 participants
Started: May 25, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors9 locations
NCT06150144
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
PHASE3Recruiting
40 participants
Started: May 25, 2023 · Completed: May 25, 2025
2 conditions2 sponsors1 location
NCT05433116
Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC
PHASE2Recruiting
50 participants
Started: May 25, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor10 locations
NCT07215754
Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients
N/ARecruiting
300 participants
Started: May 25, 2023 · Completed: May 31, 2031
1 condition1 sponsor1 location
NCT05851326
Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome
NARecruiting
126 participants
Started: May 25, 2023 · Completed: Oct 31, 2025
3 conditions7 sponsors6 locations
NCT05871853
Get the Benefits From the Start. Improving Breastfeeding
N/ARecruiting
1,600 participants
Started: May 25, 2023 · Completed: Dec 31, 2028
1 condition4 sponsors1 location
NCT06341660
To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
30 participants
Started: May 25, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location